Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial

MLA

Chen, Tom Wei-Wu, et al. “Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.” JAMA Oncology, vol. 10, no. 3, Mar. 2024, pp. 325–34. EBSCOhost, https://doi.org/10.1001/jamaoncol.2023.5456.

APA

Chen, T. W.-W., Dai, M.-S., Tseng, L.-M., Chen, S.-C., Chao, T.-Y., Chao, T.-C., Chang, Y.-C., Chiu, C.-F., Liu, C.-T., Lin, C.-H., Liu, C.-Y., Chen, Y.-F., Chang, D.-Y., Yu, J.-C., Rau, K.-M., Hsieh, Y.-Y., Shen, S.-C., Huang, S.-M., Cheng, A.-L., & Lu, Y.-S. (2024). Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial. JAMA Oncology, 10(3), 325–334. https://doi.org/10.1001/jamaoncol.2023.5456

Chicago

Chen, Tom Wei-Wu, Ming-Shen Dai, Ling-Ming Tseng, Shin-Cheh Chen, Tsu-Yi Chao, Ta-Chung Chao, Yuan-Ching Chang, et al. 2024. “Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.” JAMA Oncology 10 (3): 325–34. doi:10.1001/jamaoncol.2023.5456.